AGL Stock Recent News

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international partic.

T, AGL and ALTO have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2023.

agilon health, Inc. (AGL) Q4 2023 Earnings Call Transcript

The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Agilon Health (AGL) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.14 per share a year ago.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the fourth quarter and full year 2023 after the market closes on Tuesday, February 27, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for.

The provider of support services for primary care physicians anticipates medical margins for fiscal 2023 of between $340 million and $360 million, down from an earlier forecast of $455 million to $470 million.

Shares of Agilon Health Inc. AGL, -0.25% were indicated down more than 1% in Friday's premarket, after the health care services company lowered its 2023 margin outlook, citing higher costs, but provided an upbeat 2024 outlook. “Higher-than-expected costs became visible to us in mid-December during the November close process given updated data from health plans and will impact our FY2023 medical margins,” said Chief Executive Steve Sell.

agilon health's full-year outlook caused its stock to fall sharply, raising concerns about the sustainability of its business model. While the company reported a 71% increase in revenue and a rise in Medicare Advantage membership, its gross profit growth doesn't hold up. A $5 billion market cap appears too high, considering agilon's low medical margins.

Start Time: 16:30 January 1, 0000 5:29 PM ET agilon health, inc. (NYSE:AGL ) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 PM ET Company Participants Steve Sell - CEO Tim Bensley - CFO Matthew Gillmor - VP, IR Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Gary Taylor - Cowen Jailendra Singh - Truist Securities George Hill - Deutsche Bank Whit Mayo - Leerink Partners Adam Ron - Bank of America Jamie Perse - Goldman Sachs Elizabeth Anderson - Evercore ISI Thomas Kelliher - RBC Capital Markets Jack Wallace - Guggenheim Operator Hello, everyone.